Acurx Pharmaceuticals, Inc. ACXP
Set alert
1.07 USD +0.03 +2.88%
At close · Nov 2
1.12 +0.05 +4.67%
After hours · Nov 2, 4:00 PM ET
1.05 Day range 1.11
1.04 52-week range 7.54
- YTD
- -57.03%
- 1 year
- -78.69%
- Open
- 1.08
- Prev close
- 1.04
- Mkt cap
- 5.85M
- Vol
- 143.67K
- Avg vol
- 118.93K
- EPS
- -2.67
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.05
- High
- 1.11
- Forward P/E
- -0.56
- Beta
- -1.72
- Short ratio
- 12.59
- Inst. own
- 11.96%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 9, 2024
- 50-d avg
- 1.46
- 200-d avg
- 2.00
- 1y target
- 11.19
6M chart
Signals (19)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 26, 2026 | 1 week ago |
| RSI: Oversold | Oct 16, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 14, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 10, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 28, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Aug 18, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 16, 2026 | 3 months ago |
| SMA: Bullish | Jul 15, 2026 | 3 months ago |
| RSI: Oversold | Jun 25, 2026 | 4 months ago |
| RSI: Oversold | Jun 22, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 17, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 9, 2026 | 4 months ago |
| MACD: Buy Signal | May 6, 2026 | 6 months ago |
Analyst view
Consensus: buy
Buy
Price target (mean) 11.19 +945.8% upside
Now 1.07
- Target (low)
- 10.00
- Target (mean)
- 11.19
- Target (high)
- 12.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy2
- Buy0
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
- 2 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.18 | -0.18 – -0.18 | -0.38 | +52.6% | 0 | 0.0% | 1 |
| Next quarter | -0.38 | -0.38 – -0.38 | -0.28 | -35.7% | 0 | 0.0% | 1 |
| Current year | -0.89 | -0.89 – -0.89 | -1.15 | +22.6% | 0 | 0.0% | 1 |
| Next year | -2.06 | -2.06 – -2.06 | -0.89 | -131.5% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 10, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 12, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 19, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 28, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 15, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 15, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 13, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 15, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 15, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 11, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 17, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Dec 19, 2022 | HC Wainwright & Co. | Initiated | — | Buy |
| Oct 20, 2022 | Alliance Global Partners | Initiated | — | Buy |
| Nov 29, 2021 | Maxim Group | Initiated | — | Buy |